Skip to main content
Clinical Trials/NCT05225428
NCT05225428RecruitingNot Applicable

Video Education With Result Dependent dIsclosure

Dana-Farber Cancer Institute1 site in 1 country1,020 target enrollmentStarted: August 4, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
1,020
Locations
1
Primary Endpoint
Video Education Acceptability (Qualitative Interview Study)

Study Overview

Brief Summary

The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.

Detailed Description

This study consists of two parts:

  • Qualitative assessment:

  • This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review. Participation in the study will be considered complete after the interview is finished. The qualitative assessment study will recruit 20 total participants.

  • The data gathered from this study will inform the refinement and adaptation of the VERDI model for the subsequent randomized controlled trial.

  • Randomized control trial:

  • A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling in 1000 participants

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
  • Ability to understand spoken or written English or Spanish in a healthcare context
  • Ability to understand and the willingness to sign a written informed consent document
  • Black or Latinx (qualitative assessment study only)

Exclusion Criteria

  • Prior cancer genetic testing
  • Prior germline genetic testing
  • Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
  • Currently pregnant
  • Currently incarcerated

Arms & Interventions

QUALITATIVE ASSESSMENT

Experimental

This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review.

It is expected that about 20 people will take part in this part of the research study.

In the larger part of the study that will happen after this part of the study, it is expected 1000 people will participate.

Intervention: Video Education (Behavioral)

RCT-VERDI

Experimental

A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling

Intervention: Video Education (Behavioral)

RCT-Genetic Counseling

Experimental

A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling

Intervention: Genetic Counseling (Behavioral)

Outcomes

Primary Outcomes

Video Education Acceptability (Qualitative Interview Study)

Time Frame: 3 Weeks

Pre- and post-test of knowledge of hereditary cancer risk and cancer genetic counseling with qualitative patient interview question domains and instruments to assess understanding of language and imagery of video education as correlated with measures of health literacy.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Huma Rana, MD

Principal Investigator

Dana-Farber Cancer Institute

Study Sites (1)

Loading locations...

Similar Trials